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The distribution of deaths by cause provides crucial information
for public health planning, response, and evaluation. About 60%
of deaths globally are not registered or given a cause, limiting
our ability to understand disease epidemiology. Verbal autopsy
(VA) surveys are increasingly used in such settings to collect
information on the signs, symptoms, and medical history of people
who have recently died. This article develops a novel Bayesian
method for estimation of population distributions of deaths by
cause using verbal autopsy data. The proposed approach is based
on a multivariate probit model where associations among items
in questionnaires are flexibly induced by latent factors. Using
the Population Health Metrics Research Consortium labeled data
that include both VA and medically certified causes of death, we
assess performance of the proposed method. Further, we estimate
important questionnaire items that are highly associated with causes
of death. This framework provides insights that will simplify future
data collection.
1. Introduction. The distribution of causes of death is an essential
part of understanding population dynamics, as well as implementing and
evaluating effective public health interventions (e.g. Ruzicka and Lopez,
1990; Mathers et al., 2005; Soleman et al., 2006; Bloomberg and Bishop,
2015). Monitoring cause of death requires understanding both acute, rapid
onset epidemiological crises (e.g. the outbreak of an infectious diseases) and
observing changes over the course of decades (e.g. the rise in obesity re-
lated diabetes). The “gold-standard” for assigning cause of death relies on
physical autopsies with pathological reports. In low-resource settings, how-
ever, most deaths happen outside of hospitals and are often not recorded
by a civil registration and vital statistics systems (Mikkelsen et al., 2015).
Keywords and phrases: Bayesian latent model, cause of death, conditional dependence,
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In such settings, understanding the mortality burden of a specific cause,
and trends in cause-specific mortality over time, is extremely challenging
(e.g. Phillips et al., 2015; de Savigny et al., 2017). In-person autopsies take
valuable physician time away from patients to perform autopsies and are
extremely difficult or impossible for deaths that happen outside of the hos-
pital, meaning that any insights are generalizable only to the small fraction
of the population that regularly interacts with the healthcare system.
Scaling up to a system that can record all deaths presents massive finan-
cial and logistical challenges, meaning that local and national governments
must rely on lower cost alternatives. One common approach is to sue surveys
with relatives or caretakers of the decedent. There is, naturally, much less
information in a survey-based system than in a physical autopsy and there
are numerous data quality challenges. Nonetheless, given the lack of credible
alternatives, survey-based data are and will continue to be vital for under-
standing cause of death distributions (Horton, 2007; AbouZahr et al., 2007;
Jha, 2014). Survey-based data for cause of death assessment are known
as verbal autopsies (VAs) and consist of interviews with a family mem-
ber or other individual familiar with the death. The respondent answers a
questionnaire about the signs, symptoms, demographic characteristics and
health history of the deceased individual. Deaths are typically identified us-
ing community informants or using a partial surveillance system. Interviews
are conducted by specially trained enumerators, some of whom have medical
expertise. VA surveys are widely conducted (Lopez, 1998; Yang et al., 2005;
Maher et al., 2010; Sankoh and Byass, 2012), and the World Health Orga-
nization (WHO) releases a standardized VA questionnaire to facilitate com-
parison across areas (World Health Organization, 2012, 2017; Nichols et al.,
2018).
Given VA surveys, there are several available methods to estimate a cause
of death based on the reported symptoms. In some settings, trained clinicians
review VAs and assess a cause of death (Lozano et al., 2011). This approach
can be effective in some circumstances, but is time-consuming and requires
that trained clinicians (many of whom would otherwise be seeing patients)
be available. An alternative approach is to use an algorithmic or statistical
method to assign causes of death. Several such methods have been proposed
and evaluated in the statistics and public health literatures (see for example
James et al., 2011; Byass et al., 2012; Serina et al., 2015; Miasnikof et al.,
2015; McCormick et al., 2016).
For the most part, these methods rely on a critical assumption: inde-
pendence across symptoms conditional on a given cause. This assumption
disregards critical information about constellations or clusters of symptoms
3that are typical of a given cause and thus particularly informative when as-
signing causes. The only method currently available that uses information
about dependence between symptoms is work by King and Lu (King and Lu,
2008; King et al., 2010). The King and Lu method regresses the probability
of random subsets of symptoms on the conditional probability of the selected
symptoms given a cause. This process is an attempt to represent the space of
all possible symptom combinations. However since there are typically one to
two hundred symptoms, exploring all possible combinations is an extremely
daunting task, which is often impossible in reasonable time.
Our work presents a novel approach to incorporating dependence between
symptoms in assigning cause of death from VA surveys. In our approach,
we capture dependence between symptoms using a small number of latent
factors. This approach avoids the need to evaluate all possible symptom
combinations as in the King and Lu framework. We build a multivariate
probit model for symptoms conditional on a cause. Binary-scale outcomes
can be interpreted as a manifestation of underlying continuous variables.
A factor model on these conditional variables provides a sparse covariance
structure between symptoms. Our method also accommodates missing data
that commonly arise in VA surveys, because for example, family members
may not remember all details about sign/symptoms of the deceased person.
The proposed approach can incorporate both individual-specific and design-
based missing values by summing them out from the probit model with a
missing-at-random assumption. We fit the model using an efficient Markov
chain Monte Carlo (MCMC) algorithm we develop for posterior computa-
tion. Further, we utilize our framework to better understand the importance
of each measure in the questionnaire. To do this, we quantify the associa-
tion between each symptom with each cause, using a model-based version of
Crame´r’s V . Our measures can be used to simplify and shorten future VA
surveys, decreasing both the burden on respondents and the cost.
The remainder of the paper is organized as follows. This section describes
labeled VA data from the Population Health Metrics Research Consortium
(PHMRC) that will be the primary data source we use in our analysis. Sec-
tion 2 proposes a novel approach for estimation of population distributions
of causes of death using a small number of latent factors. Section 3 develops
an efficient MCMC algorithm. Section 4 assesses the performance of the pro-
posed approach in various scenarios and measures strength of dependence of
questionnaire items in the PHMRC dataset. Section 5 concludes the article.
1.1. PHMRC VA survey. The Population Health Metrics Research Con-
sortium (PHMRC) collected VA data at six study sites in four countries:
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Andhra Pradesh, India; Bohol, Philippines; Dar es Salaam, Tanzania; Mex-
ico City, Mexico; Pemba Island, Tanzania; and Uttar Pradesh, India. In each
study site, VAs were collected for adults, children and neonates in hospital
and clinical environments. Causes were assigned based on diagnostic criteria
including laboratory, pathology and medical imaging findings. Murray et al.
(2011) provide the detailed criteria for each cause, which were developed
by a committee of physicians involved in the study. The cause list was con-
structed based on WHO global burden of disease estimates of the leading
causes of death in the developing world. VA interviews were conducted with
a relative of the deceased by interviewers who were blinded to the cause of
death assigned in the hospital, and the family member provided the consent
for the VA study. The VA questionnaire items cover symptoms of illnesses,
demographic characteristics, diagnoses of chronic illnesses by health service
providers, possible risk factors such as tobacco-use and other potentially
contributing characteristics. In typical settings where VA surveys are imple-
mented, it is not possible to obtain a large fraction of deaths with physician
codes. The PHMRC data are, therefore, intended to be used as training
data for statistical and algorithmic methods used in settings where only VA
surveys are available. Murray et al. (2011) provide detailed information of
the design and implementation of the PHMRC study, and PHMRC (2013)
released a version of the dataset to the public after removing potentially
identifying information from the original VA interviews. The lists of causes
of death and predictors in our analysis are in the supplementary materials.
Figure 1 shows the barplot of 34 pre-defined causes of death for adults
in the PHMRC data, and those for each study site are in the supplemen-
tary materials. We observe that there is a large difference in the number
of deaths between causes, for example 630 in stroke and 40 in esophageal
cancer, and distributions of the causes vary considerably among the sites.
The VA questionnaire consists of binary, count and categorical items. Ex-
isting statistical and algorithmic tools for assigning cause of death from VA
surveys dichotomize categorical and continuous variables. We use the pro-
cedure described in Murray et al. (2011) and McCormick et al. (2016) to
convert all indicators into binary variables, leading to a dataset with 7,841
individuals and 175 symptoms/indicators. Dichotomizing continuous and
categorical variables no doubt loses some information, but it also facilitates
greater comparability with current state of the art methods for VA classifi-
cation. Building models for high dimensional, mixed-scale variables remains
a challenging open area of research. An additional feature of the PHMRC,
and all VA data, is the presence of abundant missing values. These occur for
several reasons, including difficulty recalling specific circumstances of a per-
5son’s death. Figure 2 shows the histogram of the missing rate of the binary
predictors. We observe many predictors contain missing values and in some
cases the missingness is extreme, with more than half of questions missing
answers.
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Fig 1. Barplot of 34 causes of death in the PHMRC data. We follow PHMRC (2013) in
the numbering of the causes.
Since the PHMRC data contain medically-certified causes, we can explore
the magnitude of the dependence between symptoms for a given medically-
certified cause. We compute Crame´r’s V (Crame´r, 1946) that measures
strength of associations between two variables, taking a value from 0 (no
association) to 1 (complete association). Figure 3 shows the result for all
pairs of predictors for deaths due to AIDS related causes. We conducted chi-
squared test using the R function cramersV in the lsr package (Navarro,
2015; R Core Team, 2016), and the hypothesis of independence was rejected
6 KUNIHAMA ET AL.
with 5% significance level for 1669 pairs of the predictors out of 15225 pairs.
Using Fisher’s exact test, the hypothesis was rejected with 5% significance
level for 1843 pairs. Unlike most of the previously available methods, our
proposed method will utilize these correlations to improve cause assignment
accuracy.
2. Bayesian factor model for VA data. In this section we present
our model formulation. First we present the modeling framework, and then
we discuss how to assess the importance of symptoms.
2.1. Bayesian approach. We propose a novel Bayesian framework for as-
sessing cause of death using VA surveys. Let yi ∈ {1, . . . , C} be the cause
of death of the ith person with i = 1, . . . , n, and xi = (xi1, . . . , xip)
′ be
the responses to questions j = 1, . . . , p with xij ∈ {0, 1}. One approach
would be to directly build a conditional probability of a person having died
from a certain condition given a set of observable covariates pi(yi |xi) us-
ing standard parametric models (e.g. multinomial probit/logit regressions).
Modeling these conditional probabilities directly is unappealing, however,
since we have a high fraction of missing data (see Figure 2), we would also
need to impute a substantial fraction of symptoms. Performing these impu-
tations would require choosing an imputation model, which would bring with
it particular assumptions about the structure of the data. Overall, it is not
straightforward to build a flexible model for high dimensional binary data
with complex interactions, and there is a possibility that the imputation
model may fail to capture an actual structure of the data.
Given the challenges with imputing missing values, we opt instead for
a Bayesian framework where we can integrate over missing symptoms. To
do this, we first express the conditional distribution, pi(yi |xi), using Bayes’
rule:
pi(yi |xi) =
pi(xi | yi)pi(yi)∑C
c=1 pi(xi | yi = c)pi(yi = c)
.
In this framework we can integrate out missing values from pi(xi | yi). Let
xobsi and x
mis
i denote the observed and missing items for the ith person with
xi = (x
obs
i , x
mis
i ). We assume missing data are missing at random, i.e., the
probability of the missing-data mechanism depends on observed data but not
on the missing values (Rubin, 1976; Seaman et al., 2013; Mealli and Rubin,
2015). Under this assumption, one can conduct inference on parameters in
a model using only observed information. We utilize the distribution of the
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Fig 2. Histogram of the missing rate of the predictors. The horizontal and vertical axes
show the missing rate and counts of the predictors.
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Fig 3. Crame´r’s V between predictors for the deaths caused by AIDS. The horizontal
and vertical axes present the index of each predictor. Details of the predictors are in the
supplementary materials. The scale on the right hand side shows the value of Crame´r’s V.
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cause given the observed items,
pi(yi |x
obs
i ) ∝ pi(x
obs
i | yi)pi(yi), where pi(x
obs
i | yi) =
∫
pi(xi | yi)dx
mis
i .
If the integral can be calculated analytically, we can evaluate the conditional
probabilities of the cause on the observed information without imputing
missing data. Without assuming missing at random, an additional model
is needed to describe the missing-data mechanism. In the case of VA data,
however, we do not have the requisite information. Missing data could arise
because respondents were asked a question but did not recall the answer.
This is expected since the interview is about a traumatic event, requires
recalling specialized details, and often does not happen until months after
the death. Missing data could also arise because interviewers, perhaps with
an eye towards a likely cause, strategically asked certain questions or asked
questions in a specific order. An active area of research in the VA community
involves gathering ethnographic and numeric data to describe the VA inter-
view process, with the hopes of making the process more standard across
contexts and understanding missing data mechanisms. Utilizing information
about the interview and respondent recall processes, to construct a missing
data model still remains an open area of research. Therefore, in the absence
of an alternative missing data model, we can enhance the plausibility of
the assumption by incorporating as many variables as possible in a model
(Little and Rubin, 2002; Gelman et al., 2013).
Under the Bayes’ rule representation, there are two pieces of the model
that we need to specify, (i) the unconditional distribution of individual
causes, pi(yi), and (ii) the conditional distribution of observed symptoms
given an individual has a particular cause, pi(xi | yi). Beginning with the
prior distribution for causes, we assume a Dirichlet distribution,
{pi(yi = 1), . . . , pi(yi = C)} ∼ Dirichlet(a1, . . . , aC)
where a1, . . . , aC are concentration parameters. Since cause patterns can
differ substantially across geographic areas and times, we assume we have
little prior information about the distribution of causes. We therefore assume
a1 = · · · = aC = 1, leading to a uniform prior with pi(yi = c) ∝ 1 for
c = 1, . . . , C.
The second piece, pi(xi | yi), requires modeling a set of high-dimensional
binary predictors given each cause. As described previously, nearly all exist-
ing methods for assigning cause of death from verbal autopsies make the as-
sumption of conditional independence across symptoms (Byass et al., 2012;
9Miasnikof et al., 2015; McCormick et al., 2016),
pi(xi | yi) =
p∏
j=1
pi(xij | yi).
This assumption facilitates computation but disregards substantial and po-
tentially informative relationships between symptoms, as Figure 3 shows.
To flexibly capture dependence, we develop a conditional distribution
based on the multivariate probit model. In our framework, each binary
outcome is a manifestation of an underlying continuous variable. Let zi =
(zi1, . . . , zip)
′ ∈ Rp be the latent variable for the ith person. We express
the multivariate binary variable xi by transforming the continuous variable
zi. We assume a multivariate normal distribution conditional on a cause,
zi | yi ∼ N(µyi ,Σyi) with mean µyi = (µyi1, . . . , µyip)
′ and covariance Σyi .
Even for moderately large p, estimating p(p + 1)/2 parameters in the
covariance matrix will be challenging, particularly since we expect that each
dataset will contain only a few deaths by each cause. Further, since our
goal is predicting cause of death for a new sample of deaths, we prefer a
sparse model to avoid overfitting. Rather than estimating all elements in the
covariance matrix, we introduce a K-dimensional factor ηi = (ηi1, . . . , ηiK)
′
with K ≪ p, and propose the following sparse factor model,
xij = 1(zij > 0), j = 1, . . . , p,
zi = µyi + Λyiηi + εi, ηi ∼ N(0, IK), εi ∼ N(0, Ip),(1)
where 1(·) is an indicator function and Λy = {λyjk} is a p×K loading matrix
with y = 1, . . . , C, j = 1, . . . , p and k = 1, . . . ,K. Dependence is induced in
zi by integrating out the factor ηi in (1), leading to the normal distribution
with cause-dependent mean and covariance,
zi | yi ∼ N(µyi ,ΛyiΛ
′
yi
+ Ip),
where the number of parameters in the covariance reduces from p(p+1)/2 to
Kp. In practice, we will need to choose the number of factors, K, which we
propose doing via cross validation. For the prior distribution of the mean and
factor loadings, we use Cauchy distributions, a standard shrinkage prior with
high density around zero and heavy tails. The Cauchy prior reduces effects
of redundant elements, but will also capture meaningful signals. Based on
the normal-gamma distribution, we express the Cauchy distribution as
µyj ∼ N(0, τ
−1
j ), τj ∼ Ga(0.5, 0.5),
λyjk ∼ N(0, φ
−1
j ), φj ∼ Ga(0.5, 0.5),
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where Ga(a, b) denotes the gamma distribution with mean a/b. The latent
variables τj and φj are shared among the causes and factors for reduction
of the number of parameters in the model.
In a factor model, constraints on the factor loadings are necessary to iden-
tify the latent factors (Arminger and Muthe´n, 1998; Lopes and West, 2004;
Zhou et al., 2014). In our context, though, identification is not necessary
since the factors are a way to reduce the dimension of the covariance ma-
trix, rather than to be interpreted in and of themselves. We opt not to use
constraints for identification since interpreting the factors is not a goal and
constraints can lead to order dependence and computational inefficiencies
(Bhattacharya and Dunson, 2011; Montagna et al., 2012).
2.2. Measuring strength of association. VA surveys collect information
via questionnaires with many items regarding demographic background,
health history and disease symptoms. It can be time-consuming and costly
in terms of both enumerator time and the toll on a person close to the dece-
dent to ask redundant questions that will not be useful in predicting likely
cause of death. We now propose a method for assessing the importance of
each symptom based on the strength of association with causes of death.
For two discrete random variables y ∈ {1, . . . ,my} and x ∈ {1, . . . ,mx},
Dunson and Xing (2009) develop a Bayesian measure of association relying
on the parameters which characterize the multivariate distribution,
δ2 =
1
min{my,mx} − 1
my∑
c=1
mx∑
d=1
{P (y = c, x = d)− P (y = c)P (x = d)}2
P (y = c)P (x = d)
,
(2)
where δ ranges from 0 to 1 with δ ≈ 0 if y and x are independent. If the
joint and marginal probabilities are replaced by the empirical distributions,
δ will correspond to Crame´r’s V . Therefore, δ can be considered a model-
based version of Crame´r’s V . In the proposed model, it is straightforward to
evaluate the probability functions in (2). For example, the joint probability
of the cause and jth predictor is expressed as pi(yi, xij) = pi(xij | yi)pi(yi)
where pi(xij | yi) is the proposed factor model and pi(yi) is the Dirichlet
distribution. In the following section, we describe how the measure can be
incorporated into our posterior sampling algorithm.
3. Posterior computation. The posterior density for the model pre-
sented in Section 2.1 is not available in closed form. We instead approximate
the posterior density using samples obtained through Markov-chain Monte
Carlo (MCMC). Let mi = (mi1, . . . ,mip)
′ be a vector of indicators denoting
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missing values for the ith person such that mij = 1 if xij is missing and
mij = 0 if xij is observed with j = 1, . . . , p. We define notation [mi] such
that, for a vector b and a matrix B with p rows, b[mi] and B[mi] denote
the subvector and submatrix consisting of components with mij = 0 for
j = 1, . . . , p. Then we propose the following MCMC algorithm.
1. Update µ·j ≡ (µ1j , . . . , µCj)
′ from N(µ∗,Σ∗) for j = 1, . . . , p with
µ∗ = Σ∗aj , Σ∗ = diag
{
(n1 + τj)
−1, . . . , (nC + τj)
−1
}
,
where nc =
∑n
i=1 1(yi = c,mi = 0) and aj is the C × 1 vector with
the cth element
∑n
i=1 1(yi = c,mi = 0)(zij − λ
′
yij·
ηi) where λyij· =
(λyij1, . . . , λyijK)
′.
2. Update λcj· ≡ (λcj1, . . . , λcjK)
′ from N(µλ,Σλ) for c = 1, . . . , C with
µλ = Σλ


∑
i:yi=c
ηi(zij − µyij)

 , Σλ =

∑
i:yi=c
ηiη
′
i + φjIK


−1
.
3. Update ηi from N(µ˜, Σ˜) for i = 1, . . . , n with
µ˜ = Σ˜Λ′yi[mi](zi − µyi)[mi], Σ˜ =
(
Λ′yi[mi]Λyi[mi] + IK
)−1
.
4. Update τj for j = 1, . . . , p from
Ga
(
C + 1
2
,
∑C
c=1 µ
2
cj + 1
2
)
.
5. Update φj for j = 1, . . . , p from
Ga
(
CK + 1
2
,
∑C
c=1
∑K
k=1 λ
2
cjk + 1
2
)
.
6. Update zij with mij = 0 for i = 1, . . . , n and j = 1, . . . , p from{
N+(µyij + λ
′
yij·
ηi, 1) if xij = 1,
N−(µyij + λ
′
yij·
ηi, 1) if xij = 0,
where N+ and N− denote the truncated normal distributions with
support [0,∞) and (−∞, 0] respectively.
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7. For a person i ∈ S where S is the target data, generate yi with
pi(yi = c |x
obs
i ) =
pi(xobsi | yi = c)pi(yi = c)∑C
y=1 pi(x
obs
i | yi = y)pi(yi = y)
, c = 1, . . . , C,
where pi(xobsi | yi = c) =
∫
pi(xobsi | η, yi = c)f(η)dη is evaluated using a
Monte Carlo approximation with ηr ∼ N(0, IK) for r = 1, . . . , R,
pi(xobsi | yi = c) ≈
1
R
R∑
r=1


∏
j:mij=0
pi(xij | ηr, yi = c)

 .(3)
Then, compute the population distribution of causes of death by(
1
#S
∑
i∈S
1(yi = 1), . . . ,
1
#S
∑
i∈S
1(yi = C)
)
where #S is the number of observations in the test data.
For the estimation of strength of dependence in Section 2.2, Step 7 above is
replaced by
7. Update the distribution of causes pi(yi) with Dirichlet(1, . . . , 1) prior
from
Dirichlet
(
1
n
n∑
i=1
1(yi = 1) + 1, . . . ,
1
n
n∑
i=1
1(yi = C) + 1
)
,
and compute δ in (2) for each predictor.
As mentioned previously, we need to specify the number of latent fac-
tors, K. In Section 4, we selected the number of factors by 5-fold cross-
validation. More details are in the supplementary materials. In addition,
we set R = 200 as the number of random samples for the Monte Carlo
method in (3) and generated 5,000 MCMC samples after the initial 500
samples were discarded as a burn-in period, and every 10th sample was
saved. Discarding samples in this way is a widely-used approach known as
thinning and is designed to reduce autocorrelations in a Markov chain (Hoff,
2009; Gelman et al., 2013). We observed that the sample paths were stable,
and the sample autocorrelations dropped smoothly. Illustrative examples
of the sample plot and the autocorrelation are in the supplementary ma-
terials. Replication code for the proposed method is publicly available at
https://github.com/kunihama/VA-code.
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4. Results. Using the MCMC algorithm described in the previous sec-
tion, we fit our model to the PHMRC VA data. We are particularly interested
in the improvement that comes from explicitly accounting for dependence
between symptoms. We evaluate whether incorporating dependence between
symptoms improves prediction of the distribution of deaths by cause in a
target population. As an assessment of the performance, we utilize cause
specific mortality fraction (CSMF) accuracy, which is a measure of close-
ness between two probability vectors in the VA literature (McCormick et al.,
2016),
CSMF Accuracy = 1−
dL1(pi0, pi)
2{1−min1≤c≤C pi0(y = c)}
,
where dL1 indicates L1 distance between two distributions and dL1(pi0, pi) =∑C
c=1 |pi0(y = c) − pi(y = c)|. It is a transformation of L1 distance such
that a larger value indicates that two probability vectors are closer and it
equals to 1 if they are the same. The true CSMF, pi0, is approximated by
the empirical distribution of causes of death in the test data, and pi is the
estimated distribution of causes of death by a statistical model. In addition,
as another measure of the performance, we compute the correlation between
the actual and estimated numbers of deaths per cause.
An important consideration in our evaluation is whether the method
works when the cause of death distribution (and possibly the relationship
between symptoms and causes) varies between the training and testing set.
To be clear, we are assuming that the underlying “true” population rela-
tionship between testing and training remains the same, but that we will
have limited training data so our model could be highly sensitive to spurious
associations between some symptoms and the rare causes that exist in our
training sample. This consideration is fundamental in the VA setting since
obtaining training data is extremely costly and the fraction of deaths due
to each cause can change between testing and training data. For example,
in many settings, training data are collected from one geographic area and
need to be used for predicting the distribution of deaths by cause at another
area. In evaluating the method, we consider realistic scenarios where we es-
timate the distribution of deaths by cause in one area using training data
collected from different geographic areas. We study six scenarios in which
each of the PHMRC sites is treated as a target site and the rest together
as training data. We observe discrepancies in the distributions of deaths by
cause between the test and training data in all scenarios. Especially, the case
where the test site is Pemba Island shows a relatively large difference in the
distributions of causes. The figure is in the supplementary materials.
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Fig 4. Boxplot of CSMF accuracy by Bayesian factor model (BF), conditionally indepen-
dent model (CI), InSilicoVA (InSilico), InterVA, King-Lu method (KingLu) and Tariff for
scenarios where the target sites are Andhra Pradesh (top left), Bohol (middle left), Dar
es Salaam (bottom left), Mexico City (top right), Pemba Island (middle right) and Uttar
Pradesh (bottom right). For each scenario, L1 indicates L1 distance between the empirical
distributions in the test and training data. A larger L1 distance means a larger difference
between the distributions.
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Fig 5. Boxplot of correlation between the actual and predicted numbers of deaths per cause
by Bayesian factor model (BF), conditionally independent model (CI), InSilicoVA (InSil-
ico), InterVA, King-Lu method (KingLu) and Tariff for scenarios where the target sites
are Andhra Pradesh (top left), Bohol (middle left), Dar es Salaam (bottom left), Mex-
ico City (top right), Pemba Island (middle right) and Uttar Pradesh (bottom right). For
each scenario, L1 indicates L1 distance between the empirical distributions in the test and
training data. A larger L1 distance means a larger difference between the distributions.
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119.Was decedent in any way paralyzed?
174.Gender: Female
147.Did decedent have excessive bleeding after delivery or abortion?
140.Was decedent pregnant at the time of death
41.Had decedent lost weight in 3 months before death?
14.Did decedent have heart disease?
172.Was injury or accident intentionally inflicted by others?
12.Did decedent have diabetes?
5.Did decedent have TB?
171.Was injury or accident self−inflicted?
132.Did decedent have ulcers in breast?
146.Did decedent die within 6 weeks of childbirth?
6.Did decedent have AIDS?
131.Did decedent have swelling or lump in breast?
8.Did decedent have cancer?
0.4 0.5 0.6 0.7 0.8
Delta
Fig 6. Boxplot of δ for top 15 predictors in descending order of the posterior mean. The
index of each predictor is in the supplementary materials.
We compare the proposed method with state of the art VA classification
algorithms. In addition to the conditionally independent model, we employ
methods currently used in practice: InSilicoVA (McCormick et al., 2016), In-
terVA (Byass et al., 2012), King-Lu (King and Lu, 2008; King et al., 2010)
and Tariff (James et al., 2011; Serina et al., 2015). These methods assign
causes without the information about constellations or clusters of symp-
toms. King-Lu is the exception that takes into account dependence between
symptoms but it can incorporate only a small subset of symptoms at a
time. On the other hand, the proposed method can jointly model all pre-
dictors without the assumption of conditional independence. Details of the
competitors are in the supplementary materials.
Figure 4 reports the boxplot of CSMF accuracy for each scenario. It shows
the proposed method works well, producing the accuracy equal to or higher
than the competitors in all scenarios. As for the competitors, the order
changes in each scenario, and InterVA and Tariff often report small values.
Although King-Lu takes into account dependence between symptoms, the
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performance can be lower than the other competitors with the assumption
of conditional independence. This is probably because it relies on modeling
of small subsets of predictors. All the methods show relatively low values in
the scenario where the target site is Pemba Island with the largest gap of
the distributions of causes between the target and training sites. Figure 5
shows the boxplot of correlation between the actual and predicted numbers
of deaths per cause. The result is similar in that the proposed method works
as well as or better than the competitors in all scenarios, and the values are
relatively small for all the methods in the scenario with the target site Pemba
Island. In addition, we conduced the sensitivity analysis of the prior and the
number of random samples in (3) for the proposed method and obtained
stable results given in the supplementary materials.
Turning now to results for the measure of strength of association between
the causes and predictors, we estimate δ in Section 2.2 using the proposed
model. As in Figure 2, some items show high missing rates, and to obtain
robust results, we include only predictors with a missing rate less than 5%.
Figure 6 reports the boxplot of δ for top 15 predictors. We observe that sev-
eral items related to medical history show high dependence such as cancer
and TB. There are also other types of items in the list. For example, predic-
tors 140, 146, 147 are questions for women about pregnancy and childbirth,
and predictors 171 and 172 are about injuries. The estimation result of δ for
other predictors are in the supplementary materials. In addition, we com-
pute the dependence measure in a cause-specific way by transforming the
original variable with 34 causes into a binary variable taking 1 for a certain
cause and 0 for the rest. The result indicates that important predictors vary
with each cause. For example, a set of questions related to paralysis show
relatively strong dependence with stroke, while the association of the medi-
cal history is much higher than other predictors in AIDS. These results are
in the supplementary materials.
5. Discussion. In the VA literature, there have been various statistical
approaches for estimation of population distributions of causes of death. The
key is how to model high dimensional binary predictors given a cause with
many missing values. For simplicity, existing methods analyze survey data
under strong assumptions such as conditional independence between symp-
toms. The contribution of this article is to analyze the PHMRC data using
a new Bayesian method that flexibly captures complex interactions between
symptoms without the restrictive assumption. In the proposed framework,
one can measure strength of dependence of each symptom with the causes,
which can be useful for the selection of questionnaire items in a future survey.
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One future direction is to incorporate spatial information into the pro-
posed model. Factors affecting cause of death vary through space depending
on geographic characteristics, so two sites that are close to each other should
largely share the same factors affecting cause of death. Therefore it may
be more efficient to estimate distributions of deaths by cause by weighting
more on neighboring areas. In addition the relationship between causes and
questionnaire items may depend on space. Although this article assumes
the conditional distribution of the symptoms given a cause is constant over
space, one can extend it to pi(x | y, s) with spatial information s.
Another direction for future work is to generalize the proposed framework
for survey weights. To save cost and time many social surveys employ special
data-collection designs such as stratified sampling that produce a biased
sample. To adjust for a gap between the sample and the population, survey
weights are constructed and distributed along with the data. When faced
with data like that, it is necessary to incorporate the weights into statistical
models for prediction.
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Supplementary materials for “Bayesian factor models for
probabilistic cause of death assessment with verbal autopsies”
1 PHMRC data in the analysis
Figures 1-6 report the barplot of causes of death for each study site and Tables 1-5 show
the lists of causes of death and predictors in our analysis. We follow PHMRC (2013) in the
numbering of the causes. Following McCormick et al. (2016), the predictors are selected and
transformed into dichotomous variables except that we use the female indicator as gender
and skip the question for which no individual answered yes.
2 Difference in distributions of causes of death
Figure 7 shows differences in empirical distributions of causes of death between test and
training data in Section 4.
3 Competitors
The conditionally independent model predicts a cause of death by pi(yi |xi) ∝
∏p
j=1 pi(xij | yi)
where beta(1,1) prior is assumed for pi(xij | yi), leading to the posterior distribution, beta(1+∑n
i=1 1(xij = 0,mij = 0), 1 +
∑n
i=1 1(xij = 1,mij = 0)) where mij is the missing indicator
taking 1 if xij is missing and 0 if observed. The MCMC setting is the same as the proposed
method in Section 3.
InterVA (Byass et al., 2012) is one of the most popular automatic VA coding methods
and has been extensively used in the practice. InterVA calculates the propensity of each
cause given the symptoms that are present. The original InterVA algorithm uses a list of
physician-provided conditional probabilities of observing a symptom given each cause, in
the form of rankings, without training data. It was later adapted to learn these conditional
probabilities from training data in McCormick et al. (2016).
Tariff (James et al., 2011) algorithm, as populated by the SmartVA-Analyze software,
calculates the ranking of causes given observed symptoms using an additive score-based
method. It should be noted that a modified algorithm, “Tariff 2.0”, was proposed in Serina et al.
(2015) with adjustments based on additional knowledge that is not publicly available. A dis-
cussion of the implementation was provided in the supplement materials of McCormick et al.
(2016). Unlike the methods that calculate individual cause assignments first and then ag-
gregate to population distributions of causes, InSilicoVA (McCormick et al., 2016) provides
a Bayesian framework that assumes a generative model characterizing both CSMF at the
population level, and the cause of death distributions at the individual level.
All of the above methods assume the symptoms are conditionally independent given the
underlying cause of death. King-Lu (King and Lu, 2008; King et al., 2010) is the only other
1
method taking into account the dependence between symptoms. It estimates the population
distribution of causes directly by constrained least square regressing on repeatedly sampled
random subsets of symptoms.
We estimate InterVA, Tariff and InSilicoVA using the R package, openVA (Li et al.,
2016b, 2018). For InterVA (Li et al., 2014) and InSilicoVA (Li et al., 2016a), the empirical
conditional probabilities of observing a symptom given a cause are first transformed into
ranks using the default InterVA interpretation table, as described in the supplement mate-
rials of McCormick et al. (2016). For InSilicoVA, we ran the MCMC for 10, 000 iterations
and saved every 10th iteration after discarding the first half of the chain. We used the
default settings for Tariff (Li et al., 2016c) and King-Lu (King and Lu, 2012). For InterVA,
Tariff and King-Lu, we evaluate uncertainty in the estimates by the bootstrap with 100
random samples from training data.
4 MCMC convergence
To investigate posterior convergence, Figure 8 shows illustrative examples of sample paths
and autocorrelations of the MCMC sample by the Bayesian factor model and the condi-
tionally independent model in each scenario in Section 4.
5 Cross validation
Figure 9 shows the estimation result of 5-fold cross validation for the selection of an optimal
number of latent factors in each scenario in Section 4.
6 Sensitivity analysis
To check the sensitivity of prior distributions, we estimated the distribution of causes of
death in each scenario in Section 4 using Gamma(a,a) prior for the precisions with a =
0.25, 0.5, 1, 2, 3. Figure 10 reports the boxplot of CSMF accuracy with these prior settings.
With respect to the number of Monte Carlo simulation, R, we check the effects on the
estimation result. Figure 11 reports the boxplot of CSMF accuracy with R = 100, 200, 300,
400, 500 in each scenario in Section 4.
7 Association between causes of death and predictors
Figure 12 displays the boxplot of δ between 34 causes of death and each predictor except
the ones with the missing rate more than 5%. Figures 13 and 14 show the boxplot of δ for
top 15 predictors in stroke and AIDS in descending order of the posterior mean.
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Table 1: List of causes of death
No. Cause of death No. Cause of death
1 AIDS 18 Leukemia/Lymphomas
2 Asthma 19 Lung Cancer
3 Bite of Venomous Animal 20 Malaria
4 Breast Cancer 21 Maternal
5 Cervical Cancer 22 Other Cardiovascular Diseases
6 Cirrhosis 23 Other Infectious Diseases
7 Colorectal Cancer 24 Other Injuries
8 COPD 25 Other Non-communicable Diseases
9 Diabetes 26 Pneumonia
10 Diarrhea/Dysentery 27 Poisonings
11 Drowning 28 Prostate Cancer
12 Epilepsy 29 Renal Failure
13 Esophageal Cancer 30 Road Traffic
14 Falls 31 Stomach Cancer
15 Fires 32 Stroke
16 Homicide 33 Suicide
17 Acute Myocardial Infarction 34 TB
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Figure 1: Barplot of causes of death in Andhra Pradesh. We follow PHMRC (2013) in the
numbering of the causes.
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Figure 2: Barplot of causes of death in Bohol. We follow PHMRC (2013) in the numbering
of the causes.
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Figure 3: Barplot of causes of death in Dar es Salaam. We follow PHMRC (2013) in the
numbering of the causes.
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Figure 4: Barplot of causes of death in Mexico City. We follow PHMRC (2013) in the
numbering of the causes.
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Figure 5: Barplot of causes of death in Pemba Island. We follow PHMRC (2013) in the
numbering of the causes.
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Figure 6: Barplot of causes of death in Uttar Pradesh. We follow PHMRC (2013) in the
numbering of the causes.
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Table 2: List of predictors: 1-44
No. Predictors
1 Did decedent have asthma?
2 Did decedent have hypertension?
3 Did decedent have obesity?
4 Did decedent have stroke?
5 Did decedent have TB?
6 Did decedent have AIDS?
7 Did decedent have arthritis?
8 Did decedent have cancer?
9 Did decedent have COPD?
10 Did decedent have dementia?
11 Did decedent have depression?
12 Did decedent have diabetes?
13 Did decedent have epilepsy?
14 Did decedent have heart disease?
15 For how long was decedent ill before s/he died?
16 Did decedent have a fever?
17 How many days did the fever last?
18 Was there a moderate to severe fever?
19 Was there a continuous fever?
20 Was there an on and off fever?
21 Did decedent have sweating with the fever?
22 Did decedent have a rash?
23 How many days did decedent have the rash?
24 Was there a rash on the face?
25 Was there a rash on the trunk?
26 Was there a rash on the extremities?
27 Was there a rash everywhere?
28 Was there a rash in other locations?
29 Was there a rash on the face? [second choice]
30 Was there a rash on the trunk? [second choice]
31 Was there a rash on the extremities? [second choice]
32 Was there a rash in other locations? [second choice]
33 Did decedent have sores?
34 Did the sores have clear fluid or pus?
35 Did decedent have itching of skin?
36 Did decedent have an ulcer (pit) on the foot?
37 Did the ulcer ooze pus?
38 For how many days did the ulcer ooze pus?
39 Did decedent experience pins and needles in their feet?
40 Did decedent have blue lips?
41 Had decedent lost weight in the three months prior to death?
42 Was there moderate to large weight loss?
43 Did decedent look pale?
44 Did decedent have yellow discoloration of the eyes?
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Table 3: List of predictors: 45-88
No. Predictors
45 For how long did decedent have the yellow discoloration?
46 Did decedent have ankle swelling?
47 For how long did decedent have ankle swelling?
48 Did decedent have puffiness of the face?
49 For how long did decedent have puffiness of the face?
50 Did decedent have general puffiness all over his/her body?
51 For how long did decedent have puffiness all over his/her body?
52 Did decedent have a lump in the neck?
53 Did decedent have a lump in the armpit?
54 Did decedent have a lump in the groin?
55 Did decedent have a cough?
56 For how long did decedent have a cough?
57 Did the cough produce sputum?
58 Did decedent cough blood?
59 Did decedent have difficulty breathing?
60 For how long did decedent have difficulty breathing?
61 Was the breathing difficulty continuous?
62 Was the breathing difficulty on and off?
63 Did the breathing difficulty get worse in the lying position?
64 Did the breathing difficulty get worse in the sitting position?
65 Did the breathing difficulty get worse in the walking position?
66 Did the breathing difficulty not get worse in any position?
67 Did the breathing difficulty get worse in the lying position? [second choice]
68 Did the breathing difficulty get worse in the sitting position? [second choice]
69 Did the breathing difficulty get worse in the walking position? [second choice]
70 Did the breathing difficulty not get worse in any position? [second choice]
71 Did decedent have fast breathing?
72 For how long did decedent have fast breathing?
73 Did decedent wheeze?
74 Did decedent experience pain in the chest in the month preceding death?
75 Did the pain last more than 24 hours?
76 Was the pain during physical activity?
77 Was there pain located in the chest?
78 Was there pain located in the left arm?
79 Was there pain located in other places?
80 Was there difficulty swallowing both solids and liquids?
81 For how long before death did decedent have loose or liquid stools?
82 Did decedent have a change in bowel habits?
83 Was there blood in the stool?
84 Was there blood in the stool up until death?
85 Did decedent stop urinating?
86 Did decedent vomit in the week preceding the death?
87 For how long before death did decedent vomit?
88 Was there blood in the vomit?
11
Table 4: List of predictors: 89-132
No. Predictors
89 Was the vomit black?
90 Did decedent have difficulty swallowing?
91 For how long before death did decedent have difficulty swallowing?
92 Was the difficulty with swallowing with solids, liquids, or both?
93 Did decedent have pain upon swallowing?
94 Did decedent have belly pain?
95 For how long before death did decedent have belly pain?
96 Was there pain in the lower belly?
97 Was there pain in the upper belly?
98 Did decedent have a more than usual protruding belly?
99 For how long before death did decedent have a protruding belly?
100 How rapidly did decedent develop the protruding belly?
101 Did decedent have any mass in the belly?
102 For how long before death did decedent have a mass in the belly?
103 Did decedent have headaches?
104 For how long before death did decedent have headaches?
105 Was the onset of the headache fast?
106 Did decedent have a stiff neck?
107 For how long before death did decedent have stiff neck?
108 Did decedent experience a period of loss of consciousness?
109 Was there a sudden loss of consciousness?
110 For how long did the period of loss of consciousness last?
111 Did it continue until death?
112 Did decedent experience a period of confusion at any time in the three months prior to death?
113 For how long did the period of confusion last?
114 Was there a sudden start to a period of confusion?
115 Did decedent experience memory loss at any time in the three months prior to death?
116 Did decedent have convulsions?
117 For how long before death did the convulsions last?
118 Did the person become unconscious immediately after the convulsions?
119 Was decedent in any way paralyzed?
120 For how long before death did decedent have paralysis?
121 Paralyzed right side (arm and leg)
122 Paralyzed other
123 Paralyzed left side (arm and leg)
124 Paralyzed lower part of body
125 Paralyzed upper part of body
126 Paralyzed one leg only
127 Paralyzed one arm only
128 Paralyzed whole body
129 Paralyzed refused
130 Paralyzed don’t know
131 Did decedent have any swelling or lump in the breast?
132 Did decedent have any ulcers (pits) in the breast?
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Table 5: List of predictors: 133-175
No. Predictors
133 Had decedent periods stopped naturally because of menopause?
134 Did decedent have vaginal bleeding after cessation of menstruation?
135 Did decedent have vaginal bleeding other than her period?
136 Was there excessive vaginal bleeding in the week prior to death?
137 At the time of death was her period overdue?
138 For how many weeks was her period overdue?
139 Did decedent have a sharp pain in the belly shortly before death?
140 Was decedent pregnant at the time of death?
141 Did decedent die during an abortion?
142 Did bleeding occur while she was pregnant?
143 Did decedent have excessive bleeding during labor or delivery?
144 Did decedent die during labor or delivery?
145 Did decedent die within 6 weeks after having an abortion?
146 Did decedent die within 6 weeks of childbirth?
147 Did decedent have excessive bleeding after delivery or abortion?
148 Did decedent have bad smelling vaginal discharge within 6 weeks after delivery or abortion?
149 Did decedent use tobacco?
150 Type of tobacco used: cigarettes
151 Type of tobacco used: pipe
152 Type of tobacco used: chewing
153 Type of tobacco used: local tobacco
154 Type of tobacco used: other
155 Type of tobacco used: refused
156 Type of tobacco used: don’t know
157 How much pipe/chewing tobacco did decedent use daily?
158 How many cigarettes did decedent smoke daily?
159 Did decedent drink alcohol?
160 Did decedent drink moderate-high amounts of alcohol?
161 Did decedent drink low amounts of alcohol?
162 Did decedent suffer road traffic injury?
163 Did decedent suffer fall?
164 Did decedent suffer drowning?
165 Did decedent suffer poisoning?
166 Did decedent suffer bite/sting?
167 Did decedent suffer burn?
168 Was decedent a victim of violence?
169 Decedent did not suffer any injuries
170 Did decedent suffer other injury?
171 Was the injury or accident self-inflicted?
172 Was the injury or accident intentionally inflicted by someone else?
173 How long did decedent survive after the injury?
174 Gender: female
175 Age
13
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Figure 7: Empirical distributions of causes of death in test and training data in Section 4.
The left side shows the scenarios that the target sites are Andhra Pradesh (AP), Bohol and
Dar es Salaam (Dar). The right side corresponds to Mexico City (Mexico), Pemba Island
(Pemba) and Uttar Pradesh (UP). At the top of each figure, L1 indicates the L1 distance
between the two distributions.
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Figure 9: Estimation result of 5-fold cross validation in the scenarios where the target sites
are Andhra Pradesh (top left), Bohol (middle left), Dar es Salaam (bottom left), Mexico
City (top right), Pemba Island (middle right) and Uttar Pradesh (bottom right). The
horizontal and vertical axes represent the number of factors and the posterior mean of
CSMF accuracy. The red circle indicates the point with the highest accuracy.
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Figure 10: Boxplot of CSMF accuracy with Gamma(a,a) prior for the precisions with
a = 0.25, 0.5, 1, 2, 3 in the scenarios where the target sites are Andhra Pradesh (top left),
Bohol (middle left), Dar es Salaam (bottom left), Mexico City (top right), Pemba Island
(middle right) and Uttar Pradesh (bottom right). The horizontal and vertical axes show
the hyperparameter a and CSMF accuracy.
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Figure 11: Boxplot of CSMF accuracy with R = 100, 200, 300, 400, 500 in the scenarios
where the target sites are Andhra Pradesh (top left), Bohol (middle left), Dar es Salaam
(bottom left), Mexico City (top right), Pemba Island (middle right) and Uttar Pradesh
(bottom right). The horizontal and vertical axes represent the number of the Monte Carlo
simulation and CSMF accuracy.
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Figure 13: Boxplot of δ for top 15 predictors in stroke in descending order of the posterior
mean.
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Figure 14: Boxplot of δ for top 15 predictors in AIDS in descending order of the posterior
mean.
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